A Single-Center Randomized Controlled Trial on the Impact of Disease Subtype-Based Active Video Education on Bowel Preparation Quality in Patients With Inflammatory Bowel Disease

NCT07582731 | Not Yet Recruiting

• 1 other identifier: KY20262099-F-1
• Study Type: interventional
• Target: 300
• Locations: 0 countries
• Sites: N/A

Brief Summary

This single-center, prospective, randomized controlled trial evaluates whether disease subtype-based active video education improves bowel preparation quality in patients with inflammatory bowel disease (IBD) undergoing colonoscopy. 300 IBD patients will be randomized 1:1 to standard education plus subtype-specific video education (intervention) or standard education alone (control). Primary outcome: Boston Bowel Preparation Scale (BBPS) score.

Conditions

Inflammatory Bowel Diseases

Outcome Measures

Primary Outcomes (1)

• Bowel Preparation Quality (Boston Bowel Preparation Scale, BBPS)

  The Boston Bowel Preparation Scale (BBPS) is a validated scoring system to assess the cleanliness of three colonic segments: right colon (including cecum and ascending colon), transverse colon (including hepatic flexure and splenic flexure), and left colon (including descending colon, sigmoid colon, and rectum). Each segment is scored from 0 (unprepared) to 3 (excellent) by the endoscopist during withdrawal. The total BBPS score ranges from 0 to 9. Higher scores indicate better bowel preparation.

  Periprocedural (during colonoscopy)

Secondary Outcomes (8)

• Adequate Bowel Preparation Rate

  Periprocedural (during colonoscopy)

• Excellent Bowel Preparation Rate

  Periprocedural (during colonoscopy)

• Cecal Intubation Rate

  Periprocedural (during colonoscopy)

• Cecal Intubation Time

  Periprocedural (during colonoscopy)

• Bowel Preparation Compliance Rate

  After bowel preparation and before colonoscopy (assessed on the day of procedure)

Study Arms (2)

Intervention Group (Active Video Education Group)

EXPERIMENTAL

Patients receive conventional bowel preparation education (written instructions + 10-minute oral explanation) plus disease subtype-specific active video education delivered via WeChat. Patients are required to watch the tailored video at least once within 3 days before colonoscopy. No investigational drug or device is involved. Sample size: 150.

Behavioral: Disease Subtype-Based Active Video Education; Behavioral: standard bowel preparation education

Control Group (Conventional Education Group)

ACTIVE COMPARATOR

Patients receive only standard bowel preparation education, including unified written instructions and a 10-minute verbal explanation, with no additional video education. Sample size: 150.

Behavioral: standard bowel preparation education

Interventions

Disease Subtype-Based Active Video Education BEHAVIORAL

A structured, subtype-specific educational video program tailored for patients with inflammatory bowel disease (IBD). The videos are customized based on IBD subtype (ulcerative colitis/Crohn's disease), disease activity (active/remission), and Crohn's disease behavior (stricturing/fistulizing). It covers key topics including dietary restrictions, laxative intake instructions, symptom management, and practical problem-solving strategies to improve understanding and adherence to bowel preparation protocols. The video is delivered via WeChat link.

Also known as: WeChat-Based Personalized IBD Video Education

Intervention Group (Active Video Education Group)

standard bowel preparation education BEHAVIORAL

standard bowel preparation education

Control Group (Conventional Education Group); Intervention Group (Active Video Education Group)

Eligibility Criteria

• Age: 18 Years - 75 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Age between 18 and 75 years, inclusive.
• Confirmed diagnosis of Ulcerative Colitis (UC) or Crohn's disease (CD) according to standard clinical guidelines.
• Scheduled for elective colonoscopy for IBD monitoring or disease activity assessment.
• Able to understand written and verbal instructions and to use a smartphone to view video education materials.
• Voluntary participation with written informed consent.

You may not qualify if:

• Absolute contraindications to colonoscopy, including acute gastrointestinal perforation, fulminant colitis, toxic megacolon, or hemodynamic instability.
• History of total or subtotal colectomy.
• Acute or chronic intestinal obstruction.
• Severe cardiac, pulmonary, hepatic, or renal insufficiency (eGFR \<30 mL/min/1.73m², NYHA class III/IV).
• Severe psychiatric or cognitive impairment that prevents understanding of the study requirements.
• Inability or unwillingness to provide written informed consent.
• Pregnant or breastfeeding women.

Sponsors & Collaborators

• Jie Liang: lead

MeSH Terms

Conditions

Inflammatory Bowel Diseases

Condition Hierarchy (Ancestors)

Gastroenteritis; Gastrointestinal Diseases; Digestive System Diseases; Intestinal Diseases

Central Study Contacts

Jie Liang, MD, PhD

CONTACT

029-84771535; liangjie@fmmu.edu.cn

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Masking Details: Outcome assessors (endoscopists evaluating bowel preparation quality and research staff collecting data) will be blinded to participants' group assignment to minimize assessment bias.
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Professor

Study Record Dates

• First Submitted: May 6, 2026
• First Posted: May 13, 2026
• Study Start (Estimated): June 1, 2026
• Primary Completion (Estimated): June 1, 2027
• Study Completion (Estimated): July 1, 2027
• Last Updated: May 13, 2026

Record last verified: 2026-05

Data Sharing

• IPD Sharing: Will not share